- Location
Denervation System
"-
Recor Medical Announces Major Advances in Its Paradise System for Renal Denervation
Feb 7, 2014ReCor Medical has announced major advances in its Paradise System for renal denervation (RDN), confirming its commitment to lead in the treatment of patients with resistant hypertension (HTN). The company announced that it has received ...
Tags: renal denervation system, health, HTN
-
Renal Denervation as a High Blood Pressure Treatment Is Looking Less Exciting by The Day
Jan 23, 2014Renal denervation as a high blood pressure treatment is looking less exciting by the day, with the latest bad news coming from Covidien. The Dublin, Ireland–based medical device giant said Tuesday that it will exit its OneShot renal ...
-
Medtronic Willfully Infringed on an Edwards Lifesciences' Patent
Jan 16, 2014Medtronic willfully infringed on an Edwards Lifesciences’ patent with its CoreValve transcatheter heart valve, and owes Edwards nearly $394 million in damages and patent royalties, a federal jury in Delaware found Wednesday. Edwards ...
Tags: Medtronic, CoreValve, transcatheter heart valve, Edwards
-
Randomization of First Patients in Symplicity HTN-4 Trial is declared by Medtronic
Dec 19, 2013US-based medical technology company Medtronic has announced the randomization of the first patients in the SYMPLICITY HTN-4 clinical trial at Medical University of South Carolina, Piedmont Heart Institute and Duke University Medical Center. ...
-
CE Mark Approval for Symplicity Spyral Catheter Is Announced by Medtronic
Dec 9, 2013Medtronic, a medical technology company, has announced CE Mark approval in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its Symplicity Spyral catheter and Symplicity G3 radio frequency (RF) generator. ...
Tags: Medtronic, medical technology
-
Medtronic Obtained a Device Exemption From FDA to Initiate Symplicity Htn-4 Clinical Trial
Nov 7, 2013Medtronic has obtained an investigational device exemption from the US Food and Drug Administration (FDA) to initiate SYMPLICITY HTN-4 clinical trial using its Symplicity renal denervation system. SYMPLICITY HTN-4 study has been designed ...
-
Preliminary Data From Global Symplicity Registry Is Unveiled by Medtronic
Sep 4, 2013Medtronic has unveiled new data from the Global SYMPLICITY Registry, a multi-centre, prospective, observational registry designed to collect comprehensive data evaluating procedural and long-term safety of the Symplicity renal denervation ...
Tags: Medtronic, Symplicity Registry
-
St Jude Medical Asserted That EnligHTN Renal Denervation Technology Reduces Blood Pressure
May 24, 2013St. Jude Medical, a medical device firm, has announced that its EnligHTN Multi-Electrode Renal Denervation System offers a safe, rapid and sustained reduction in measurements of blood pressure after a year. The company presented the new ...
Tags: EnligHTN Renal, Blood Pressure
-
Medtronic Has Completed Randomizing Symplicity HTN-3
May 24, 2013Medtronic has completed randomizing Symplicity HTN-3, a clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. Renal denervation is a minimally invasive, catheter-based procedure that decreases the ...
Tags: Medtronic, Randomizing Symplicity
-
St Jude Medical Has Commenced Its Enlightnment Clinical Study
May 23, 2013US-based medical device company St Jude Medical has commenced its EnligHTNment clinical study. The EnligHTNment study will assess whether the EnligHTN Multi-Electrode Renal Denervation System can minimize the risk of major cardiovascular ...
Tags: St Jude Medical, Clinical Study
-
St. Jude Medical Has Enrolled The First Patient for The Enlightn III Trial
May 16, 2013St. Jude Medical, a US-based medical device company, has enrolled the first patient for the EnligHTN III trial. During the study, the safety and performance of the second-generation EnligHTN Renal Denervation System in patients with ...
-
Medtronic Has Submitted IDE to Initiate Symplicity Renal Denervation System Study
Mar 12, 2013Medtronic has submitted its investigational device exemption (IDE) application to the FDA to initiate a study of its Symplicity renal denervation system for the treatment of uncontrolled hypertension in patients with systolic blood pressure ...
-
Commence EnligHTN Renal Denervation System Study Will Be Commenced by St Jude
Feb 19, 2013St Jude Medical is planning to begin EnligHTNment study, designed to evaluate whether patients with hypertension treated with its EnligHTN renal denervation system can provide additional benefits beyond a reduction in blood pressure. The ...
Tags: Medical, minimally invasive device, EnligHTN
-
First Patient ia enrolled by St Jude Medical in EnligHTN II Trial
Feb 1, 2013St Jude Medical has enrolled the first patient in EnligHTN II trial of its multi-electrode renal denervation technology for treating patients with drug-resistant hypertension. The CE-marked EnligHTN renal denervation system, which ...
Tags: EnligHTN II trial, Medical, drug resistant hypertension
-
Oneshot Renal Denervation System Is Launched by Covidien
Jan 18, 2013Covidien has introduced a new therapeutic device to treat patients with resistant hypertension. The CE-marked OneShot Renal Denervation system is an over the wire balloon-based irrigated catheter device which is implanted under the skin ...
Tags: Denervation System, Health, Medicine, resistant hypertension